Latest News

Huntington disease prevention trial shows creatine safe, slows progression

The first clinical trial of a drug intended to delay the onset of symptoms of Huntington disease reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most participants. In addition, neuroimaging showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • CEOs who motivate with 'fightin' words' shoot themselves in the foot

  • Knowledgeable consumers more likely to buy when given fewer options

  • Targeting the brain to treat obesity

  • Early warning sign for babies at risk of autism: Early joint attention predicts later autism symptoms

  • Creating sustainable STEM teacher programs

  • Klotho: neuroprotective against Alzheimer's disease

  • Cell therapy for multiple sclerosis patients: Closer than ever?

  • Computerized ADHD testing

  • Charter schools nationwide more cost-effective, produce greater ROI

  • 'Quack' child psychology practices identified by study

  •